Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

4-Bromo-2-Methoxypyrimidine

    • Product Name 4-Bromo-2-Methoxypyrimidine
    • Alias 4-Bromo-2-methoxypyrimidine
    • Einecs EINECS 620-261-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    160691

    Productname 4-Bromo-2-Methoxypyrimidine
    Casnumber 884495-45-6
    Molecularformula C5H5BrN2O
    Molecularweight 189.01
    Appearance White to off-white solid
    Meltingpoint 62-66°C
    Purity Typically ≥98%
    Solubility Soluble in organic solvents (e.g., DMSO, methanol)
    Smiles COC1=NC=NC(Br)=C1
    Inchi InChI=1S/C5H5BrN2O/c1-9-5-3-7-2-4(6)8-5/h2-3H,1H3
    Storage Store at 2-8°C, protected from light
    Synonyms 4-Bromo-2-methoxy-pyrimidine

    As an accredited 4-Bromo-2-Methoxypyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 4-Bromo-2-Methoxypyrimidine

    Applications of 4-Bromo-2-Methoxypyrimidine in Industrial Manufacturing

    4-Bromo-2-Methoxypyrimidine is a valuable intermediate for advanced chemical synthesis, supporting key segments of API, agrochemical, and specialty material manufacturing. As the original manufacturer, we maintain complete batch traceability and technical support to facilitate integration in industrial environments, enabling consistent results in regulated downstream processes. Below, we detail the most prominent application scenarios built around this intermediate.

    1. Pharmaceutical Active Pharmaceutical Ingredient (API) Synthesis – Anti-viral Drug Development

    This compound serves as a heterocyclic coupling intermediate for nucleoside analogue synthesis in anti-viral drug discovery platforms. Medicinal chemistry teams incorporate it primarily at the pyrimidine ring functionalization stage, supporting specific halogenation for further Suzuki or Buchwald–Hartwig cross-coupling processes, streamlining the custom assembly of bioactive molecules used in clinical research and production settings.

    Industry compliance standards

    • ICH Q7: Good Manufacturing Practice for APIs
    • USP, Ph. Eur., JP applicable monographs for finished APIs
    • EU EMA and US FDA regulatory guidelines for intermediates
    • ISO 9001:2015 Quality Management Systems in pharmaceuticals

    Typical usage ratio

    • Usual charging: 0.8–1.3 molar equivalents relative to core scaffold (exact ratio tailored by target nucleoside derivative and downstream reactivity requirements)

    Downstream process integration

    • Charged at the heterocycle introduction or halogen exchange stage of small molecule multi-step synthesis; typically coupled with amine, boronic acid, or stannane partners under Pd-catalyzed conditions, followed by further protection/deprotection and purification steps

    Final product types

    • Anti-viral bulk APIs (e.g., ribavirin derivatives, investigational nucleoside analogues)
    • Late-stage API process intermediates supplied to contract drug manufacturers (CDMOs)

    2. Crop Protection Active Compound Manufacturing

    Agrochemical producers use this pyrimidine building block in the synthesis of selective herbicides and fungicides, specifically where methoxylated and brominated pyrimidine cores are desired for biological activity. The raw material is upstream in Suzuki coupling, followed by downstream sulfonation or amide bond formation steps to customize the core structure, facilitating adaptation to evolving resistance profiles in the field.

    Industry compliance standards

    • FAO/WHO Guidelines on Pesticide Specifications
    • REACH (EC No. 1907/2006) Registration for chemical intermediates
    • ISO 9001:2015 QMS in agrochemical manufacturing
    • OECD Principles of Good Laboratory Practice for active ingredient development

    Typical usage ratio

    • Charged at 1.0 molar equivalent relative to target pyrimidine ring in batch or continuous-flow synthesis (ratio fine-tuned based on the desired substitution pattern and biological screening data)

    Downstream process integration

    • Added during the aromatic core assembly or halogen exchange stage; subsequent steps include alkylation, acylation, and chlorination, tailored toward intended field performance and environmental profile

    Final product types

    • Pyrimidine-based herbicide technical concentrates for blending (e.g., selective post-emergence herbicides)
    • Fungicidal actives for suspension concentrates, wettable granules, and crop protection formulations

    3. Pharmaceutical Process Intermediate – Oncology API Synthesis

    Chemical development teams employ this compound as a scaffold modifier in the synthesis of pyrimidine-based anticancer agents. The intermediate is particularly well-suited for constructing halogenated and alkoxy-substituted pharmacophores, entering the route after initial amination but before the final glycosylation or cyclization stage, which is crucial for tailoring molecular interactions with DNA or kinase targets.

    Industry compliance standards

    • ICH Q11: Development and Manufacture of Drug Substances
    • GMP compliance under US FDA 21 CFR Part 211 and EMA EudraLex Volume 4
    • Ph. Eur. or USP monographs for structurally related cytotoxic APIs
    • ISO 17025:2017 for analytical laboratories validating process intermediates

    Typical usage ratio

    • Batch introduction at 0.9–1.1 molar equivalents (balanced against residual halide, optimized by pilot process chemistry yield and purity targets)

    Downstream process integration

    • Added at the targeted ring halogenation or alkoxylation step, prior to API scaffold closure; followed by column purification, crystallization, and transfer to high-containment oncology manufacturing suites

    Final product types

    • Cytostatic API technicals
    • Advanced phase bulk intermediates for branded and generic oncology pipelines

    4. Pharmaceutical Discovery – Small Molecule Library Synthesis for High-Throughput Screening

    Research and development divisions at pharmaceutical and biotech firms utilize this compound in combinatorial chemistry platforms for generating diverse pyrimidine derivatives, supporting the rapid identification of lead compounds during high-throughput screening. Automated parallel synthesis systems incorporate small-scale charge volumes in array formats, allowing structure-activity optimization of heterocycles targeting kinases, viral enzymes, or metabolic pathways.

    Industry compliance standards

    • OECD Principles of Good Laboratory Practice (GLP) in non-clinical safety studies
    • Pharma R&D compliance: US FDA 21 CFR Part 312 (IND), EMEA guidance for early phase development
    • Lab QC standards: ISO 17025 accredited analytical methods for purity and identity
    • Internal SOPs for controlled substance handling in screening libraries

    Typical usage ratio

    • Usually 0.1–0.2 mmol per reaction well (micro-scale), with ratios precisely set per combinatorial design and reaction compatibility requirements

    Downstream process integration

    • Dosed via automated liquid handling following primary fragment coupling, facilitating rapid diversity introduction into pyrimidine libraries prior to purification and analytical QC

    Final product types

    • Low milligram-scale pyrimidine compound plates for HTS
    • Internal screening compound collections for medicinal and computational chemistry pipelines

    5. Fine Chemical Synthesis – OLED and Electronic Material Intermediates

    Manufacturers of organic electronic materials select this compound as a precursor for constructing brominated pyrimidine moieties in functional organic semiconductors. The distinctive substitution pattern enables tight control of electronic properties during iterative functionalization, with downstream application in solution-processable electronic inks and emissive materials for OLED research and production.

    Industry compliance standards

    • ISO 9001:2015 and ISO 14001:2015 (environmental controls) in fine chemical manufacturing
    • IEC 61249 (material safety for organic electronics)
    • RoHS (Restriction of Hazardous Substances) if designed for consumer electronics
    • Toxicological screening as required by downstream industrial QC

    Typical usage ratio

    • Fed at 1 molar equivalent to functionalized aryl groups; minor excess (1.05 equiv) tolerated to ensure complete coupling, adjusted by polymer chain length and final spectral requirements

    Downstream process integration

    • Dosed during C–N or C–C cross-coupling polymerization reactions forming the electronic material backbone; post-coupling workup and stripping of process solvents, followed by thin film casting or solution blending for device assembly

    Final product types

    • Pyrimidine-functionalized small molecules for OLED emitters
    • Building blocks for organic field-effect transistor (OFET) materials
    • Advanced functionalized electronic ink precursors
    Free Quote

    Competitive 4-Bromo-2-Methoxypyrimidine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    4-Bromo-2-Methoxypyrimidine: A Closer Look at a Key Chemical Building Block

    Opening Up the World of Functionalized Pyrimidines

    Every so often, a new ingredient comes along and quietly changes the conversation in the way chemistry labs and pharmaceutical research centers approach their daily challenges. 4-Bromo-2-Methoxypyrimidine belongs to this group. Its molecular structure — combining bromine at the 4-position and methoxy at the 2-position of pyrimidine — creates more than just a tangible substance in a bottle. You see, this particular setup introduces qualities that synthetic chemists value when time, accuracy, and complexity all get thrown into the same mix.

    Over years spent collaborating with scientists in medicinal chemistry, I've seen how compounds like this drive both incremental progress and big leaps. Back in my grad school days, the search for precise, selective building blocks came up in nearly every group meeting. That thrill when a reliable new reagent lands on a shelf and actually does what it promises? That's what 4-Bromo-2-Methoxypyrimidine can bring to a project.

    Getting to Know 4-Bromo-2-Methoxypyrimidine

    Unlike run-of-the-mill halogenated pyrimidines, this compound brings together bromine’s reactivity and the stabilizing, electron-donating influence of methoxy. That setup impacts how downstream reactions play out, especially in cross-coupling chemistry. Researchers trust molecules like this to forge new C–C and C–N bonds in everything from kinase inhibitor programs to agricultural chemistry projects. A simple synthetic step gains not only efficiency but also reliability when this reagent sits in the starting lineup.

    The chemical comes as an off-white to light tan solid, with a straightforward molecular formula of C5H5BrN2O. Using a compound with high purity — often better than 97% by HPLC — matters enormously for anyone looking to avoid side reactions and headaches later in a synthesis. Working with material that decomposes unpredictably or carries moisture doesn’t help anyone chasing a multi-step target. Those small facts may sound everyday, but in my time at the bench, it’s these boring details that make or break an R&D timeline.

    Practical Uses in the Synthesis Lab

    Let’s talk about what makes 4-Bromo-2-Methoxypyrimidine stand out once the actual chemistry begins. The bromo group at the 4-position acts as an excellent leaving group, primed for Suzuki-Miyaura, Buchwald-Hartwig, or other coupling reactions. Imagine starting a medicinal chemistry campaign searching for new central nervous system agents. Access to this specific pyrimidine means researchers can introduce unique aromatic or heteroaromatic partners in the next synthetic step.

    This opens up not just new possibilities, but practical time savings. Need to swap functional groups or work up a quick library of analogs? Having a strong, yet well-behaved, bromo position lets chemists test more ideas and keep the bench work moving. I’ve seen teams trim weeks off screening and scale-up just by choosing the right intermediate from the beginning. There's a remarkable satisfaction in watching a project roll forward because the chemistry lines up on the first try.

    The methoxy group delivers its own set of benefits. Beyond being a simple electron donor, the group tweaks both reactivity and solubility, making downstream steps smoother. In some synthetic routes—especially where you’re introducing more sensitive or costly moieties—the right side-chain can tip the balance between try-and-fail and get-it-right-the-first-time. If you’ve ever sat in a meeting rehashing why yesterday’s coupling stalled, you know exactly how valuable this can be.

    How It Measures Up: Differences from Other Halogenated Pyrimidines

    Across pyrimidine chemistry, plenty of related molecules are available: 2-bromopyrimidine, 4-chloropyrimidine, 2-methoxypyrimidine, and others. At first glance, the options look endless. In real practice, though, each difference in substitution pattern shapes the behavior. The bromo group is generally more reactive in palladium-catalyzed coupling reactions than chlorine, trimming reaction times or opening the door to milder conditions. Anyone who’s spent a day troubleshooting a stubborn coupler will appreciate the bump in reactivity bromine brings over chlorine.

    Methoxy substitution at the 2-position, rather than, say, a methyl or hydrogen, can also drive selectivity. Methoxy is a stronger electron donor than methyl, which can help activate the ring toward nucleophilic aromatic substitution without sending the reaction off-track. I’ve watched teams puzzle over yields until they realized this kind of fine-tuning was the missing link.

    Plus, compared to similar frameworks with a fluoro or iodo moiety, bromo strikes a good balance between cost and reactivity. I recall a scaled-up process where switching to an iodinated version exploded the raw material bill with no perceptible benefit. That’s the sort of lesson you only learn by sweating those details—not from a catalog listing.

    Pushing Forward in Drug Discovery and Beyond

    In drug discovery, speed and flexibility are currency. Using 4-Bromo-2-Methoxypyrimidine means researchers can step into complex chemical space quickly, testing more candidates before funding (and energy) runs thin. That’s something I’ve experienced first-hand: the further you push new scaffolds, the better your odds of seeing biological activity that surprises you in a good way.

    Look at recent years in anti-viral research, for instance. Pyrimidine-based scaffolds show up everywhere from kinase inhibitors to anti-cancer agents to crop protection solutions. The synthetic points of entry offered by reliable halogenated pyrimidines fuel these advances, because they connect a basic aromatic ring structure with more elaborate or functionalized partners. When combing through stacks of published SAR data, the subtle differences in backbone or substitution often spell the difference between a dead end and a promising lead.

    Industries outside pharmaceuticals, too, pull value from pyrimidine-based chemistry. Agrochemical companies rely on these backbones for new pest-control molecules. Material science teams use them as platforms for advanced electronic or photonic materials. I spent time at a contract research organization, and every quarter brought in a new project driven by a subtle tweak in substitution, proving just how central these building blocks have become.

    Why Purity and Reliability Matter

    It’s easy to forget just how much routine work in research hinges on the quality of upstream starting materials. More than once, I’ve seen progress grind to a halt because a basic building block turned out to be off-spec, or one lot showed different behavior than another. 4-Bromo-2-Methoxypyrimidine, especially in high-purity, well-characterized form, sidesteps a host of headaches. Its melting point and appearance are reliable, and good vendors supply detailed analytical data — NMR, mass spectrum, and HPLC traces — as a standard part of their package.

    Researchers benefit from not chasing down side impurities or rechecking their own work over confusing byproducts. That clear paper trail matters, whether you’re developing a preclinical candidate or validating a process before tech transfer to full-scale manufacturing.

    Choosing the Right Partner: Questions That Help

    From a practical perspective, buying or sourcing 4-Bromo-2-Methoxypyrimidine shouldn’t be a leap of faith. After years in procurement and project management, I always look for suppliers who can back up their claims with documentation: batch-specific COAs, transparent supply chains, and direct access to technical support. In a world where time and budgets slip away fast, working with a reliable partner for high-stakes intermediates matters as much as — or more than — the name on the label.

    Questions about long-term supply, batch consistency, and handling requirements help avoid future pitfalls. Will the material stand up to months in storage, or does it change state in humid air? Is the batch size standard, or does each new shipment bring in subtle differences? These small points accumulate into either smooth progress or a steady drip of lost time and productivity.

    Pitfalls and Potential Solutions

    Every building block, no matter how promising, brings its quirks. One challenge I’ve faced: working with halogenated pyrimidines sometimes means dealing with modest water solubility, especially if the downstream steps call for aqueous conditions. While replacing organic solvents, I’ve seen students try to push this compound past its solubility limits — leading to messy recoveries and off-target reactivity. Careful selection of solvents and concentrations, informed by pilot studies, helps avoid these pains.

    There’s also the question of sustainability. Many halogenated intermediates, including this one, generate some waste streams that need careful disposal. I’ve watched facility teams develop solvent recycling setups and improved waste tracking to keep the environmental impact manageable. Industry as a whole has a long road ahead, but ongoing tweaks in reaction design, like moving toward water-compatible catalysts or exploring alternatives to heavy-metal reagents, make clear progress.

    Another issue arises with scale. Small-scale academic projects rarely stress supply channels, but as soon as a molecule moves up to semifield or pilot production, questions about material sourcing, packaging, and safety data come into focus. At a previous job, I once spent months spinning wheels as our scale-up was held hostage by a vendor shipping a new intermediate in sub-gram quantities. Solid planning and early communication across regulatory, procurement, and technical teams reduces these last-minute fire drills.

    Supporting Facts from Recent Research

    Recent research underscores just how important substituent choices are in pyrimidine chemistry. A 2020 Journal of Medicinal Chemistry paper reported that simple changes in position or identity of substituents led to measurable differences in biological target engagement — even when the rest of the molecule stayed much the same. That rings true across fields. Crop protection chemists published in Pesticide Biochemistry and Physiology have leveraged 4-bromo-2-methoxypyrimidine to develop agents with improved specificity and lowered off-target toxicity.

    It’s not just about theoretical benefits, either. Process chemists detail step-by-step improvements in time saved, crude purity, and overall yield when switching from less reactive halogenated pyrimidines to those with the methoxy-bromo arrangement. These aren’t earth-shattering leaps, but on the ground, a few percent gain in yield or a shorter reaction can make enormous difference across many runs and batches.

    Pharmaceutical giants involved in kinase inhibitor research, as covered in industry white papers and conference proceedings, regularly build out synthetic plans around intermediates like 4-bromo-2-methoxypyrimidine. Having seen some data up close, I can say those published yields and process reliability figures are not just advertising—they’re mirrored in the day-to-day stories shared by bench scientists with deadlines and deliverables.

    The Bottom Line: Value in the Details

    4-Bromo-2-Methoxypyrimidine may never grab headlines or set off fireworks. Its value instead comes from how it shapes the flow of complex organic synthesis, both in research and applied settings. It helps bridge gaps in medicinal chemistry, aids agrochemical discovery, and pops up wherever tailored heteroaromatics become mission critical. Real progress in science often builds on the back of compounds like this, whose flexibility and reliability keep ambitious projects running on time.

    From my own experience, the right tool — whether a reagent, a reaction setup, or a good supplier — never feels flashy. Its importance grows as teams trust it, day after day, to deliver clean, predictable results without drama or delay. 4-Bromo-2-Methoxypyrimidine fits this model perfectly, and deserves a spot on the shelf of any lab reaching for new synthesis or new biological frontiers.

    Moving Forward: Questions Worth Asking

    The future will keep demanding more from chemical building blocks in terms of speed, reliability, and sustainability. Synthesizing the next wave of useful molecules depends on standing atop strong, proven intermediates. I suggest keeping an eye on both published literature and hard-earned anecdotes from the lab floor. Stories about successful process optimization or clever ways to manage waste streams are as valuable as complicated analytical data.

    As you weigh options for your next synthetic campaign, ask which building blocks have delivered consistent, actionable success. Try to connect not just with obvious choices, but with those compounds that let your team reach for innovation instead of spending cycles on troubleshooting and cleanup. 4-Bromo-2-Methoxypyrimidine may continue flying under the radar, but its quiet strengths will keep it right at the core of the discoveries that shape tomorrow’s chemistry and medicine.